.
MergerLinks Header Logo

New Deal


Announced

STADA to acquire 15 GSK brands.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Majority

Friendly

healthcare

Single Bidder

Cross Border

Pending

Medical Supplies

Health Care Facilities

Acquisition

Private

United Kingdom

Synopsis

Edit

STADA, a company that specializes at pharmaceuticals and non-prescription consumer health products, to acquire 15 GSK brands. Financial terms are not disclosed. The transaction represents 15 brands including Venoruton, for venous treatment, Coldrex cold remedy, Cetebe vitamin C supplements, Mebucaine sore throat range and Tavegyl allergy brand. These five brands account for just over half of the acquired brands’ combined turnover.

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US